149 related articles for article (PubMed ID: 22398969)
1. Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers.
Sistonen J; Madadi P; Ross CJ; Yazdanpanah M; Lee JW; Landsmeer ML; Nauta M; Carleton BC; Koren G; Hayden MR
Clin Pharmacol Ther; 2012 Apr; 91(4):692-9. PubMed ID: 22398969
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study.
Madadi P; Ross CJ; Hayden MR; Carleton BC; Gaedigk A; Leeder JS; Koren G
Clin Pharmacol Ther; 2009 Jan; 85(1):31-5. PubMed ID: 18719619
[TBL] [Abstract][Full Text] [Related]
3. A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk.
Kelly LE; Chaudhry SA; Rieder MJ; 't Jong G; Moretti ME; Lausman A; Ross C; Berger H; Carleton B; Hayden MR; Madadi P; Koren G
PLoS One; 2013; 8(7):e70073. PubMed ID: 23922910
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia.
Lam J; Kelly L; Ciszkowski C; Landsmeer ML; Nauta M; Carleton BC; Hayden MR; Madadi P; Koren G
J Pediatr; 2012 Jan; 160(1):33-7.e2. PubMed ID: 21880331
[TBL] [Abstract][Full Text] [Related]
5. Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine.
Madadi P; Koren G; Cairns J; Chitayat D; Gaedigk A; Leeder JS; Teitelbaum R; Karaskov T; Aleksa K
Can Fam Physician; 2007 Jan; 53(1):33-5. PubMed ID: 17872605
[TBL] [Abstract][Full Text] [Related]
6. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC
Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367
[TBL] [Abstract][Full Text] [Related]
7. Establishing causality of CNS depression in breastfed infants following maternal codeine use.
Madadi P; Shirazi F; Walter FG; Koren G
Paediatr Drugs; 2008; 10(6):399-404. PubMed ID: 18998750
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
[TBL] [Abstract][Full Text] [Related]
10. Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study.
Willmann S; Edginton AN; Coboeken K; Ahr G; Lippert J
Clin Pharmacol Ther; 2009 Dec; 86(6):634-43. PubMed ID: 19710640
[TBL] [Abstract][Full Text] [Related]
11. Putative association of ABCB1 2677G>T/A with oxycodone-induced central nervous system depression in breastfeeding mothers.
Lam J; Kelly L; Matok I; Ross CJ; Carleton BC; Hayden MR; Madadi P; Koren G
Ther Drug Monit; 2013 Aug; 35(4):466-72. PubMed ID: 23783165
[TBL] [Abstract][Full Text] [Related]
12. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers.
McLaughlin P; Mactier H; Gillis C; Hickish T; Parker A; Liang WJ; Osselton MD
J Pediatr; 2017 Nov; 190():180-184.e1. PubMed ID: 28867064
[TBL] [Abstract][Full Text] [Related]
13. Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers.
Kurtz M; Black Golde P; Berlinger N
Clin Pharmacol Ther; 2010 Dec; 88(6):760-2. PubMed ID: 21081947
[TBL] [Abstract][Full Text] [Related]
14. Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype.
Wendt FR; Sajantila A; Budowle B
Forensic Sci Int Genet; 2018 Mar; 33():48-58. PubMed ID: 29190510
[TBL] [Abstract][Full Text] [Related]
15. Effect of genetic factors on opioid action.
Kosarac B; Fox AA; Collard CD
Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in palliative care.
Kleine-Brueggeney M; Musshoff F; Stuber F; Stamer UM
Forensic Sci Int; 2010 Dec; 203(1-3):63-70. PubMed ID: 20709477
[TBL] [Abstract][Full Text] [Related]
17. Current evidence for a genetic modulation of the response to analgesics.
Lötsch J; Geisslinger G
Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919
[No Abstract] [Full Text] [Related]
18. Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.
Madadi P; Joly Y; Avard D; Chitayat DC; Smith MA; Ross CJ; Carleton BC; Hayden MR; Koren G
Clin Pharmacol Ther; 2010 Dec; 88(6):792-5. PubMed ID: 20739920
[TBL] [Abstract][Full Text] [Related]
19. The pharmacogenetics of codeine pain relief in the postpartum period.
Baber M; Chaudhry S; Kelly L; Ross C; Carleton B; Berger H; Koren G
Pharmacogenomics J; 2015 Oct; 15(5):430-5. PubMed ID: 25752520
[TBL] [Abstract][Full Text] [Related]
20. Genetic transmission of cytochrome P450 2D6 (CYP2D6) ultrarapid metabolism: implications for breastfeeding women taking codeine.
Madadi P; Ciszkowski C; Gaedigk A; Leeder JS; Teitelbaum R; Chitayat D; Koren G
Curr Drug Saf; 2011 Feb; 6(1):36-9. PubMed ID: 21241245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
